This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0883073808324769v1 24/4/431    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dastgir, J. Articles by DiMario, F. J. Search for Related Content PubMed PubMed Citation Articles by Dastgir, J. Articles by DiMario, F. J., Jr Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOPHOSPHAMIDE METHYLPREDNISOLONE Medline Plus Health Information Multiple Sclerosis Social Bookmarking                         What's this?

Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal

Dept of Pediatrics, Div of Child Neurology, Connecticut Children’s Medical Center, Hartford, and the Univ of Connecticut School of Medicine, Farmington, CT

^* To whom correspondence should be addressed. E-mail: fdimari{at}ccmckids.org.

	Abstract

Tumefactive demyelinating lesions are a known but uncommon complication of multiple sclerosis, a disease rarely reported in children. This is the case of a 16-year-old African American patient with multiple sclerosis, who developed 2 tumefactive demyelinating lesions. Review of the literature and our own experience helped formulate an algorithm for therapeutic options during an acute attack.

First published on February 2, 2009, doi:10.1177/0883073808324769

Journal of Child Neurology 2009;24:431.

A more recent version of this article appeared on April 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?